Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. Replication Medical, Inc.
483
•Replication Medical, Inc.•August 22, 2018

Replication Medical, Inc. – FDA 483, Aug 22, 2018

Record Details

During an FDA inspection conducted from July 10 to August 22, 2018, Replication Medical, Inc. of Monmouth Junction, NJ, a U.S. manufacturer of export-only medical devices, received a Form FDA 483 detailing significant quality system deficiencies. The observations highlight critical gaps in maintaining robust control over device manufacturing and quality processes.

Key issues included the absence of an approved Device Master Record for their GelFix device, indicating a fundamental lack of documented specifications. Furthermore, the firm's Corrective and Preventive Action (CAPA) system was found to be inadequate, with activities and results not properly documented. Examples include missing water sample testing, incomplete effectiveness checks, and premature closure of CAPAs. Device History Records (DHRs) for the GelFix device frequently deviated from established specifications, showing inconsistencies in manufacturing parameters such as motor speed, pressure levels, drying times, and missing "For Export Only" labeling.

The inspection also identified a lack of control over production processes, specifically the absence of a procedure for replacing water system filters, which led to prior contamination issues. Procedures for complaint trend analysis were not routinely followed, and critical document changes, such as those for the "NeuFx Lumbar Surgical Procedure," were implemented without proper review and approval through the document change request process.

These observations indicate a failure to adhere to the quality system requirements for medical device manufacturers. Replication Medical, Inc. is required to conduct thorough internal self-audits and implement comprehensive corrective actions to address all identified violations and ensure compliance with regulatory standards. Some issues were noted as "promised to correct" or "corrected and verified" during the inspection.

Company
Replication Medical, Inc.
Inspection date
August 22, 2018
Product type
devices
Office
New Jersey District Office
People
  • Ann Prewett (President)
  • Gobiga Vanniyasingam (investigator)
View Company Profile

ID · f8bf69ec-be40-4983-8891-4b8959cc9f0e

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Replication Medical, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.